Stepan Company (SCL) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
23 Feb, 2026Executive summary
2025 marked a transformational year with record safety performance, divestitures, asset optimization, and the launch of Project Catalyst targeting $100 million in pre-tax savings over two years through footprint optimization and operational efficiency.
Adjusted EBITDA grew 6% to $198.9 million, driven by disciplined pricing, cost management, and favorable mix, despite macroeconomic and sector pressures.
Organic volume increased 2% year-over-year, led by growth in crop productivity, oil field, Tier 2/3 customers, Polymers, and Specialty Products, with successful commissioning of the Pasadena, TX facility.
Positive free cash flow and improved net leverage ratio from 2.8x to 2.5x year-over-year, supported by asset optimization and working capital management.
Announced closure of Fieldsboro, NJ, and decommissioning of assets at Millsdale and Stalybridge to improve cost structure and utilization.
Financial highlights
Q4 2025 adjusted net loss was $0.5 million; reported net income was $5 million, up 49% year-over-year due to asset sale gains and non-recurring items.
Q4 adjusted EBITDA was $33.8 million, down 3% from prior year; Q4 EBITDA was $43.3 million, up 21% year-over-year.
Full-year reported net income was $46.9 million, down 7% year-over-year; adjusted net income was $41.7 million, down 17%.
Full-year EBITDA increased 11% to $208 million; adjusted EBITDA up 6% to $198.9 million.
Cash from operations in 2025 was $148 million; free cash flow was $25.4 million.
Outlook and guidance
Expect adjusted EBITDA growth and positive free cash flow in 2026, with H2 performance stronger due to margin recovery, Project Catalyst savings, and anticipated demand rebound.
Project Catalyst to deliver $60 million pre-tax savings in 2026, offsetting inflationary pressures; total $100 million targeted over two years.
Q1 2026 impacted by historic weather, with $6 million EBITDA loss, but at least half expected to be recovered in subsequent quarters.
CapEx guidance for 2026 is $105–$115 million, with effective tax rate expected to rise to 25–27% due to new US tax legislation.
Latest events from Stepan Company
- Proxy covers director elections, pay practices, auditor ratification, and strong governance.SCL
Proxy filing25 Mar 2026 - Adjusted EBITDA grew 4% in Q2 2024 despite lower net income and significant one-time expenses.SCL
Q2 20242 Feb 2026 - Q3 net income up 88% to $23.6M, EBITDA up 11%, with strong Surfactants and cost savings.SCL
Q3 202417 Jan 2026 - Net income up 42% and EBITDA up 12% on strong surfactant and specialty growth.SCL
Q1 202524 Dec 2025 - Net income up 25% and adjusted EBITDA rose 4%, with Pasadena facility to boost 2025 growth.SCL
Q4 202423 Dec 2025 - Key votes include director elections, executive pay, auditor ratification, and equity plan expansion.SCL
Proxy Filing1 Dec 2025 - Strategic investments and innovation drive growth in key markets, with renewed segment momentum in 2024.SCL
16th Annual Midwest Ideas Conference23 Nov 2025 - Q2 2025 net income rose 19% and adjusted EBITDA grew 8%, led by Polymers and Crop Productivity.SCL
Q2 202516 Nov 2025 - Q3 2025 net income fell 54%, but adjusted EBITDA and free cash flow both increased.SCL
Q3 20255 Nov 2025